← back to search

Jiheng Xu

New York University · US
Area of research
Molecular Biology · Epidemiology
Research interest
Research interests include Cancer research, Biology, Gene knockdown, Autophagy, Downregulation and upregulation, and Cell biology.
h-index
citations
811
works
18
NIH funding
primary concept
email

Recent publications

DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol
Mutation Research/Reviews in Mutation Research 2021cited by 94position: middledoi
lncRNA SNHG1 Promotes Basal Bladder Cancer Invasion via Interaction with PP2A Catalytic Subunit and Induction of Autophagy
Molecular Therapy — Nucleic Acids 2020cited by 46position: firstdoi
Oncogenic role of <i>MIR516A</i> in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy
Autophagy 2020cited by 24position: middledoi
ATG7 Promotes Bladder Cancer Invasion via Autophagy‐Mediated Increased ARHGDIB mRNA Stability
Advanced Science 2019cited by 84position: middledoi
Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis
Oncogene 2019cited by 61position: middledoi
A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-like Properties and Invasion in Human Bladder Cancer
Cancers 2019cited by 55position: middledoi
Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression
Cellular and Molecular Life Sciences 2019cited by 52position: middledoi
CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells
Oncogene 2019cited by 47position: middledoi
The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein
Cell Death and Differentiation 2019cited by 29position: middledoi
XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion
Oncogenesis 2019cited by 28position: firstdoi
Autophagy-mediated <i>Mir6981</i> degradation exhibits <i>CDKN1B</i> promotion of PHLPP1 protein translation
Autophagy 2019cited by 27position: middledoi
miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription
Molecular Therapy 2019cited by 22position: middledoi
New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating Sestrin-2 in human bladder cancer
Cancer Letters 2018cited by 47position: middledoi
XIAP overexpression promotes bladder cancer invasion <i>in vitro</i> and lung metastasis <i>in vivo via</i> enhancing nucleolin‐mediated Rho‐GDIβ mRNA stability
International Journal of Cancer 2017cited by 58position: middledoi
NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein
Neoplasia 2017cited by 57position: middledoi
p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion
Journal of Biological Chemistry 2017cited by 27position: middledoi
XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells
Oncotarget 2016cited by 33position: middledoi
Inhibition of PHLPP2/cyclin D1 protein translation contributes to the tumor suppressive effect of NFκB2 (p100)
Oncotarget 2016cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhongxian Tian · New York University15 papers (2016–2020)Chuanshu Huang · New York University13 papers (2016–2020)Xiaohui Hua · New York University11 papers (2016–2020)Haishan Huang · New York University11 papers (2016–2020)Jingxia Li · New York University10 papers (2016–2020)Junlan Zhu · New York University9 papers (2016–2019)Honglei Jin · New York University9 papers (2016–2020)Xue‐Ru Wu · New York University6 papers (2016–2021)Qipeng Xie · New York University6 papers (2017–2020)Jingxia Li · New York University5 papers (2018–2019)Guosong Jiang · New York University4 papers (2017–2020)Caiyi Chen · Nanjing University of Chinese Medicine4 papers (2017–2020)Chao Huang · Guangdong Pharmaceutical University4 papers (2019–2019)Jiawei Xu · New York University4 papers (2016–2019)Maowen Huang · New York University4 papers (2019–2020)Yisi Luo · New York University3 papers (2019–2019)Dongyun Zhang · Army Medical University3 papers (2017–2019)Mitchell D. Cohen · New York University3 papers (2019–2020)Rui Yang · New York University3 papers (2019–2020)Moon‐shong Tang · NYU Langone Health2 papers (2016–2021)